Persistence Market Research

Global Hepatitis C Virus (HCV) Antiviral Market Analysis and Forecast to 2020: Size, Share, Trends and Segments

Persistence Market Research is released new forthcoming report on title "Hepatitis C Virus (HCV) Antiviral Market: Global Industry Analysis and Forecast to 2020".


New York, NY -- (SBWIRE) -- 01/13/2015 -- Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.

Buy Full Report:

North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.

In recent times there is increased use of hepatitis C virus antiviral due to increasing incidence of chronic infection with hepatitis C virus. Increase in healthcare expenditure, changing lifestyle and increasing government initiatives are some of the key factors driving the growth for global hepatitis C virus antiviral market. In addition, increasing healthcare awareness is also fuelling the growth of global hepatitis C virus antiviral market. However, stringent regulation for approval of hepatitis C antiviral is the major factors restraining the growth for the global hepatitis C virus antiviral market.

Introduction of interferon-free oral therapies would develop opportunity for the global hepatitis C virus antiviral market. The trend for global hepatitis C virus antiviral market is rise in awareness programs and promoting partnerships by World Health Organization (WHO). Some of the major companies operating in the global hepatitis C virus antiviral market are Merck & Co., Genentech, Merck, Vertex, Janssen and Medivir AB, F. Hoffmann-La Roche, Bristol Myers Squibb, AbbVie and Gilead Sciences.

Request Full TOC:

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.